Tigason

Etretinate An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.

Molecular Formula: C₂₃H₃₀O₃

InChI: InChI=1/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+

InChIKey: InChIKey=HQMNCQVAMBCHCO-DJRRULDNBE
SMILES: CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C

Names:
    ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoate
    etretinate
    NSC297936
    Ro 10-9359
    Tigason
    2,4,6,8-Nonatetraenoic acid, 9- (4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all-E)-
    2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3, 6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all E)-
    54350-48-0

Registries:
    PubChem CID 5282375
    PubChem ID 147405